Kymera Therapeutics, Inc. Rings the Opening Bell
About This Event
Kymera Therapeutics, Inc. (Nasdaq: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Nello Mainolfi, PhD, Founder, President and Chief Executive Officer, rings the Opening Bell.